Get the Stockscreener App
40.68
9.78%
-4.41
After Hours:
40.30
-0.38
-0.93%
Hims Hers Health Inc stock is traded at $40.68, with a volume of 25.59M.
It is down -9.78% in the last 24 hours and up +4.50% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$45.09
Open:
$44.97
24h Volume:
25.59M
Relative Volume:
1.34
Market Cap:
$9.04B
Revenue:
$1.24B
Net Income/Loss:
$101.26M
P/E Ratio:
92.45
EPS:
0.44
Net Cash Flow:
$149.62M
1W Performance:
-20.72%
1M Performance:
+4.50%
6M Performance:
+180.55%
1Y Performance:
+210.06%
1-Day Range:
$39.66
$46.35
1-Week Range:
$36.02
$46.35
52-Week Range:
$11.20
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
40.68 | 9.04B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
175.59 | 411.73B | 84.35B | 15.48B | 15.47B | 6.28 |
|
UL
Unilever Plc Adr
|
57.71 | 143.80B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
92.81 | 75.83B | 20.10B | 2.89B | 3.55B | 3.52 |
|
KMB
Kimberly Clark Corp
|
143.35 | 47.55B | 20.06B | 2.55B | 2.51B | 7.55 |
|
KVUE
Kenvue Inc
|
23.79 | 45.47B | 15.46B | 1.03B | 1.34B | 0.53 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Health (NYSE:HIMS) Jumps 40% After Projecting US$2.3 Billion Revenue for 2025 - Yahoo Finance
Hims & Hers' Fall From Grace Is WarrantedStill No Margin Of Safety (NYSE:HIMS) - Seeking Alpha
Jim Cramer on Hims & Hers Health, Inc. (HIMS): ‘HIMS Just Dropped It Like, It Was Like A Led Zeppelin’ - Yahoo Finance
Hims & Hers Health Reaches Analyst Target Price - Nasdaq
Hims & Hers aired a Super Bowl ad for weight loss drugs. It alarmed health experts and senators. - AOL
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’ - AOL
Hims & Hers: A Generational Dip-Buying Opportunity - Seeking Alpha
Why Hims & Hers Health, Inc. (HIMS) Soared on Friday - Insider Monkey
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock? - MSN
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $27.00 - MarketBeat
South Dakota Investment Council Takes Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
QRG Capital Management Inc. Acquires 20,558 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading Down 25.9%Here's What Happened - MarketBeat
Handelsbanken Fonder AB Has $808,000 Stock Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) Given New $40.00 Price Target at Leerink Partners - MarketBeat
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $61.00 at Needham & Company LLC - MarketBeat
52,122 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Bought by Impact Investors Inc - MarketBeat
Hims & Hers Health (NYSE:HIMS) Shares Up 10.4% on Analyst Upgrade - MarketBeat
Michael Chi Sells 17,303 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock - MarketBeat
Piper Sandler Boosts Hims & Hers Health (NYSE:HIMS) Price Target to $35.00 - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Ieq Capital LLC - MarketBeat
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $39.00 - MarketBeat
Hims & Hers Health (NYSE:HIMS) Stock Price Up 4.9%Should You Buy? - MarketBeat
Hims & Hers Health Stock Price, Quotes and Forecasts - Benzinga
Allspring Global Investments Holdings LLC Has $292,000 Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) Trading Up 10.4% on Analyst Upgrade - MarketBeat
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $35.00 at Piper Sandler - MarketBeat
Why Hims & Hers Health Stock Sank This Week - MSN
Hims & Hers Health (NYSE:HIMS) Shares Down 3.8%What's Next? - MarketBeat
Compared to Estimates, Hims & Hers Health (HIMS) Q4 Earnings: A Look at Key Metrics - MSN
Hims & Hers Health Unusual Options Activity For February 28 - Benzinga
Can Telehealth Frontrunner Hims & Hers Health Bounce Back from its Q4 Bombshell? - Markets Insider
Hims & Hers Health (NYSE:HIMS) Stock Price Down 3.8%Here's What Happened - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Lake Street Advisors Group LLC - MarketBeat
107,858 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Purchased by Illinois Municipal Retirement Fund - MarketBeat
Hims & Hers shares drop on doubts over weight-loss business forecast - MSN
(HIMS) Technical Data - Stock Traders Daily
Hims & Hers Health (NYSE:HIMS) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Hims & Hers Health (NYSE:HIMS) Posts Earnings Results - MarketBeat
Why Hims & Hers Health Stock Is Skyrocketing Today - AOL
Hims & Hers Health (NYSE:HIMS) Trading 9.1% Higher Following Analyst Upgrade - MarketBeat
Hims and Hers Health call volume above normal and directionally bullish - TipRanks
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Versor Investments LP Has $1.36 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Q1 EPS Forecast for Hims & Hers Health Increased by Analyst - MarketBeat
Hims & Hers: Shortage-Driven Sell-Off Appears Overdone; Buy (NYSE:HIMS) - Seeking Alpha
New York State Teachers Retirement System Boosts Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers shares plunge as looming curbs on drug compounding cloud forecast - MSN
Why Hims & Hers Stock Rebounded on Wednesday - MSN
Hims & Hers warns it may stop selling compounded weight-loss drugs - MSN
Why Hims & Hers Stock Rebounded on Wednesday - The Motley Fool
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.87%
0.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):